Improved Vision-Related Function after Ranibizumab for Macular Edema after Retinal Vein Occlusion: Results from the BRAVO and CRUISE Trials

To examine the impact of intravitreal ranibizumab on patient-reported visual function using the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25) through 6 months in patients with macular edema (ME) secondary to branch or central retinal vein occlusion (RVO). Two multicenter,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Ophthalmology (Rochester, Minn.) Minn.), 2012-10, Vol.119 (10), p.2108-2118
Hauptverfasser:	VARMA, Rohit, BRESSLER, Neil M, SUNER, Ivan, LEE, Paul, DOLAN, Chantal M, WARD, James, COLMAN, Shoshana, RUBIO, Roman G
Format:	Artikel
Sprache:	eng
Schlagworte:	Activities of Daily Living Angiogenesis Inhibitors - administration & dosage Antibodies, Monoclonal, Humanized - administration & dosage Biological and medical sciences Double-Blind Method Follow-Up Studies Humans Intravitreal Injections Macular Edema - drug therapy Macular Edema - physiopathology Medical sciences Miscellaneous Ophthalmology Ranibizumab Retinal Vein Occlusion - drug therapy Retinal Vein Occlusion - physiopathology Retinopathies Sickness Impact Profile Surveys and Questionnaires Treatment Outcome Visual Acuity - physiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!